Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06798571 · ClinicalTrials.gov registry record · Phase 4
Role of Menopause in Thermoregulation
A Phase 4 study of Aging and Menopause, sponsored by Penn State University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06798571 is a Phase 4 study of Aging and Menopause that is actively recruiting participants, run by Penn State University. The registered enrollment target is 24 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06798571, a Phase 4 study of Aging and Menopause, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The frequency and severity of heat waves has increased in the last decades. Older adults (over 65 years) have impaired responses to heat stress making them at increased risk for adverse events. Previous heat waves report that women over 65 experience worse health outcomes than any other age group and age matched men. Aging and reproductive hormones, specifically estrogen, independently alter responses to heat stress. However, the combined effects of low estrogen following menopause and aging on the response to heat stress are unknown. In this study, the investigators will identify the role of estrogen in pre and post menopausal women on thermoregulatory responses to heat stress.
Interventions
- DRUG Elagolix Oral Tablet
- DRUG Estradiol patch
- OTHER cellulose placebo
- OTHER placebo patch
Study Locations (1)
Pennsylvania
- Noll Laboratory - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2026-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06798571
The ClinicalTrials.gov registry entry for NCT06798571 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 4 interventions - of which Elagolix Oral Tablet is the first listed.
NCT06798571 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06798571 about?
NCT06798571 is a clinical study titled "Role of Menopause in Thermoregulation". The frequency and severity of heat waves has increased in the last decades. Older adults (over 65 years) have impaired responses to heat stress making them at increased risk for adverse events. Previous heat waves report that women over 65 experience worse health outcomes than any other age group an...
What is the current status of trial NCT06798571?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2025-03-01. Estimated completion is 2026-07-01.
What conditions does trial NCT06798571 study?
This clinical trial studies the following conditions: Aging, Menopause.
What interventions are being tested in trial NCT06798571?
The interventions under investigation include: Elagolix Oral Tablet (DRUG), Estradiol patch (DRUG), cellulose placebo (OTHER), placebo patch (OTHER).
Who is sponsoring clinical trial NCT06798571?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06798571 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
RECRUITING · Phase 4
-
Aging, Beta Blockers, and Thermoregulatory Responses
RECRUITING · Phase 4
-
The Effect of NAD Supplementation on Brain Vascular Health in Aging
RECRUITING · Phase 4
-
Skin Barrier Function and Inflammation in Aging: The BIA Study
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.